Medical policy

Displaying 1 - 10 of 97

Investigational device exemption (IDE) studies

Requirements for IDEs approved by CMS.

Update history: LCD and article updates

View the most recent updates for our LCDs and articles.

Update history: LCD and article updates

View the most recent updates for our LCDs and articles.

Investigational device exemption (IDE) studies

Requirements for IDEs approved by CMS.

Journey to LCD coverage

Learn how the local coverage determination (LCDs) process works with this informative guide. General information on the local coverage development (LCD) process.

Journey to LCD coverage

Learn how the local coverage determination (LCDs) process works with this informative guide. General information on the local coverage development (LCD) process.

NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy

Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…

NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy

Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…

Open meeting minutes

View materials and listen to recordings from past meetings.

Open meeting minutes

View materials and listen to recordings from past meetings.